# Major Recall Alert: RIVA-Fluoxetine 10 mg Capsule Recalled Due to Exceeding Interim Acceptable Intake Limit for N-Nitroso-Fluoxetine
Consumers in Canada are being urged to take action following a major recall of RIVA-Fluoxetine 10 mg capsules. The recall was prompted by concerns that certain lots of the product may exceed the interim acceptable intake limit for **N-nitroso-fluoxetine**, a potentially harmful contaminant. If you or someone you know is using this medication, it’s crucial to stay informed to safeguard your health and well-being.
## Why This Recall is Important
This recall focuses on a serious safety issue involving **N-nitroso-fluoxetine**, which is classified as a **nitrosamine impurity**. Nitrosamines are concerning because exposure to excessive levels over time may increase the risk of certain health issues, including cancer.
The recall impacts **Laboratoire RIVA's RIVA-Fluoxetine 10 mg capsules**, a commonly prescribed medication for conditions such as depression, anxiety, and panic disorders. With the Canadian government actively monitoring nitrosamine levels in medications, this recall underscores the importance of adhering to safety standards to protect public health.
Consumers taking affected lots of the medication should be aware of potential health risks outlined in this alert and act swiftly to mitigate exposure to potentially unsafe levels of the contaminant.
## Details of the Recall
Laboratoire RIVA announced the recall via Health Canada on **October 2023**, specifying that the affected lots may contain levels of N-nitroso-fluoxetine that exceed the interim acceptable intake limit.
Here are the key details of the recall:
- **Product Name**: RIVA-Fluoxetine 10 mg Capsules
- **Manufacturer**: Laboratoire RIVA
- **Recall Reason**: Affected lots may exceed Health Canada’s acceptable intake limit for the impurity N-nitroso-fluoxetine.
- **Date of Announcement**: October 2023
- **Category**: Health/Medication Safety
- **Action Needed**: Consumers are urged to review their current medication and consult their healthcare provider immediately if they possess the affected product.
For the official recall notice and more details, you can refer to the [Health Canada publication here](https://recalls-rappels.canada.ca/en/alert-recall/riva-fluoxetine-10-mg-capsule-may-exceed-interim-acceptable-intake-limit-n-nitroso).
## What You Should Do
If you’re currently using RIVA-Fluoxetine 10 mg capsules, follow these steps to ensure your safety:
- **Check Your Lot Number**: Compare the lot number on your medication with the affected lots listed on the Health Canada recall page.
- **Contact Your Doctor or Pharmacist**: If you possess a recalled product, your healthcare provider or pharmacist can offer guidance and alternative treatment options.
- **Return the Product**: Stop taking the affected medication and return it to the pharmacy where it was purchased.
- **Monitor for Symptoms**: If you’ve been using this product, contact your healthcare provider promptly if you experience any unusual symptoms or side effects.
By acting proactively, you can reduce potential risks and maintain your health.
## Stay Safe – Get Instant Recall Alerts
Medication recalls like this one highlight the importance of staying informed in real time. To protect yourself and your family from similar safety concerns, consider downloading a **recall alert app** that provides instant notifications about recalls directly to your smartphone.
**Stay ahead of safety updates! Download our app today** to stay informed about product recalls, safety alerts, and more. Protecting your health has never been easier!
For further information about this recall, visit the official [Health Canada Recall Notice](https://recalls-rappels.canada.ca/en/alert-recall/riva-fluoxetine-10-mg-capsule-may-exceed-interim-acceptable-intake-limit-n-nitroso).